Impulsivity-anxiety-related behavior and profiles of morphine-induced analgesia in heterozygous reeler mice

Brain Research

Volumn 1131, Issue 1, 2007, Pages 173-180

  Ognibene, Elisa ^a   Adriani, Walter ^a   Granstrem, Oleg ^b   Pieretti, Stefano ^a   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Adolescence; Antipsychotic; Impulsivity; Neuropsychiatric disorder; Nociception; Reelin

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR; SCLEROPROTEIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMOTION; FEMALE; GABAERGIC SYSTEM; GENOTYPE; HETEROZYGOTE; HOT PLATE TEST; IMPULSIVENESS; INTERNEURON; LOCOMOTION; MALE; MAZE TEST; MEASUREMENT; MESENCEPHALON; MOUSE; NERVE CELL PLASTICITY; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TAIL FLICK TEST; WESTERN BLOTTING; WILD TYPE;

ANALGESICS, OPIOID; ANIMALS; ANXIETY DISORDERS; BRAIN CHEMISTRY; CELL ADHESION MOLECULES, NEURONAL; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; DRUG TOLERANCE; EMOTIONS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; IMPULSIVE BEHAVIOR; MALE; MAZE LEARNING; MESENCEPHALON; MICE; MICE, NEUROLOGIC MUTANTS; MORPHINE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PAIN; PAIN THRESHOLD; RECEPTORS, OPIOID, MU; SERINE ENDOPEPTIDASES;

ANIMALIA; MUS;

EID: 33846059754     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.11.007     Document Type: Article

References (37)

1. Adriani W., and Laviola G. Elevated levels of impulsivity and reduced place conditioning with d-amphetamine: two behavioral features of adolescence in mice. Behav. Neurosci. 117 (2003) 695-703
2. Adriani W., Della Seta D., Dessý-Fulgheri F., Farabollini F., and Laviola G. Altered profiles of spontaneous novelty seeking, impulsive behavior, and response to d-amphetamine in rats perinatally exposed to bisphenol-A. Environ. Health Perspect. 111 (2003) 395-401
3. Adriani W., Ognibene E., Daniele S., Ghirardi O., Caprioli A., and Laviola G. Motor impulsivity in Tg2576 mice, a model of Alzheimer's disease. Behav. Pharmacol. 17 5-6 (2006) 525-533
4. Ballmaier M., Zoli M., Leo G., Agnati L.F., and Spano P. Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia. Eur. J. Neurosci. 15 7 (2002) 1197-1205
5. Bartlett C.W., Gharani N., Millonig J.H., and Brzustowicz L.M. Three autism candidate genes: a synthesis of human genetic analysis with other disciplines. Int. J. Dev. Neurosci. 23 (2005) 221-234
6. Brockel B.J., and Cory-Slechta D.A. Lead, attention, and impulsive behavior: changes in a fixed-ratio waiting-for-reward paradigm. Pharmacol. Biochem. Behav. 60 2 (1998) 545-552
7. Carboni G., Tueting P., Tremolizzo L., Sugaya I., Davis J., Costa E., and Guidotti A. Enhanced dizocilpine efficacy in heterozygous reeler mice relates to GABA turnover downregulation. Neuropharmacology 46 (2004) 1070-1081
8. Chiarotti F., Alleva E., and Bignami G. Problems of test choice and data analysis in behavioral teratology: the case of prenatal benzodiazepines. Neurotoxicol. Teratol. 9 2 (1987) 179-186
9. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., and Pesold C. Dendritic spine hypoplasia and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 8 (2001) 723-742
10. Costa E., Davis J., Pesold C., Tueting P., and Guidotti A. The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr. Opin. Pharmacol. 2 (2002) 56-62
11. D'Arcangelo G., and Curran T. Reeler: new tales on an old mutant mouse. BioEssays 20 (1998) 235-244
12. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., and Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374 (1995) 719-723
13. Del Giudice M.R., Mustazza C., Borioni A., Gatta F., Tayebati K., Amenta F., Tucci P., and Pieretti S. Synthesis of 1-methyl-5-(pyrazol-3-and-5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands. Arch. Pharm. (Weinh.) 336 3 (2003 (Jun)) 143-154
14. Diatchenko L., Slade G.D., Nackley A.G., Bhalang K., Sigurdsson A., Belfer I., Goldman D., Xu K., Shabalina S.A., Shagin D., Max M.B., Makarov S.S., and Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet. 14 1 (2005 (Jan 1)) 135-143
15. Evenden J. Varieties of impulsivity. Psychopharmacology 146 (1999) 348-361
16. Fatemi S.H., Stary J.M., Halt A., and Realmuto G. Dysregulation of reelin and Bcl-2 in autistic cerebellum. J. Autism Dev. Disord. 31 (2001) 529-535
17. File S.E., and Andrews N. Anxiolytic-like effects of 5-HT (1A) agonists in drug-naive and in benzodiazepine-experienced rats. Behav. Pharmacol. 5 (1994) 99-102
18. Gainetdinov R.R., Mohn A.R., and Caron M.G. Genetic animal models: focus on schizophrenia. Trends Neurosi. 24 (2001) 52733
19. Grilli M., Toninelli G.F., Uberti D., Spano P., and Memo M. Alzheimer's disease linking neurodegeneration with neurodevelopment. Funct. Neurol. 18 (2003) 145-148
20. Guidotti A.R., Auta J., Davis J., Dwivedi Y., Grayson D., Impagniatello F., et al. Decrease in Reelin and glutamic acid decarboxylase 67 (GAD 67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57 (2000) 1061-1069
21. Holmes A., and Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci. Biobehav. Rev. 23 (1999) 971-980
22. Impagniatello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., et al. A decrease of Reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15718-15723
23. Laviola G., Adriani W., Terranova M.L., and Gerra G. Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci. Biobehav. Rev. 23 (1999) 993-1010
24. Laviola G., Macrì S., Morley-Fletcher S., and Adriani W. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci. Biobehav. Rev. 27 (2003) 19-31
25. Laviola G., Adriani W., Gaudino C., Marino R., and Flavio K. Paradoxical effects of prenatal acetylcholinesterase blockade on neurobehavioral development and drug-induced stereotypies in reeler mice. Psychopharmacology (Berlin) 184 2 (2006) 155-165
26. Linnoila M., Virkkunnen M., Scheinin M., Nuutila A., Rimon R., and Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33 (1983) 2609-2614
27. Macrì S., Adriani V., Chiarotti F., and Laviola G. Risk taking during exploration of a plus-maze is greater in adolescent than in juvenile or adult mice. Anim. Behav. 64 (2002) 541-546
28. Millan M.J. N-methyl-d-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review. Curr. Drug Targets CNS Neurol. Disord. 1 2 (2002) 191-213
29. Ognibene, E., Adriani, W., Laviola, G., in press. Neurobehavioral disorders in the infant reeler mouse model. Behav. Brain Res.
30. Pieretti S., Di Giannuario A., De Felice M., Perretti M., and Cirino G. Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides. Pain 109 1-2 (2004 (May)) 52-63
31. Podhorna J., and Didriksen M. The heterozygous reeler mouse: behavioral phenotype. Behav. Brain Res. 153 (2003) 43-54
32. Qiu S., Korwek K.M., Pratt-Davis A.R., Peters M., Bergman M.Y., and Weeber E.J. Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol. Learn Mem. 85 (2006) 228-242
33. Salinger W.L., Ladrow P., and Wheeler C. Behavioral phenotype of the reeler mutant mouse: effects of reln gene dosage and social isolation. Behav. Neurosci. 6 (2003) 1257-1275
34. Soubriè P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav. Brain Sci. 9 (1986) 319-364
35. Tueting P., Costa E., Dwivedi Y., Guidotti A., Impagnatiello F., Manev R., and Pesold C. The phenotypic characteristics of heterozygous reeler mouse. NeuroReport 10 (1999) 1329-1334
36. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psych. 155 (1998) 1661-1670
37. Zorrilla E.P. Multiparous species present problems (and possibilities) to developmentalists. Dev. Psychobiol. 30 (1997) 141-150